Is CSBTF or JEPQ a better dividend investment in 2026?

CSBTF currently yields 7.18% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: JEPQ offers higher current income.

What is the dividend yield difference between CSBTF and JEPQ?

CSBTF has a forward dividend yield of 7.18% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 3.92 percentage points.

Home › Compare › CSBTF vs JEPQ

CSBTF vs JEPQ: Dividend Comparison 2026

CSBTF yields 7.18% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 JEPQ wins by $12.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CSBTF

● Live price

7.18%

Share price

$27.85

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$32.2K

Annual income

$1,132.80

Full CSBTF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — CSBTF vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CSBTF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CSBTF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CSBTF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSBTF

Annual income on $10K today (after 15% tax)

$610.41/yr

After 10yr DRIP, annual income (after tax)

$962.88/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, JEPQ beats the other by $866.82/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSBTF + JEPQ for your $10,000?

CSBTF: 50%JEPQ: 50%

100% JEPQ50/50100% CSBTF

Portfolio after 10yr

$38.5K

Annual income

$1,642.69/yr

Blended yield

4.27%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSBTF buys

JEPQ buys

No recent congressional trades found for CSBTF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCSBTFJEPQ

Forward yield	7.18%	11.10% ✓
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$32.2K	$44.8K ✓
Annual income after 10y	$1,132.80	$2,152.59 ✓
Total dividends collected	$9.3K	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CSBTF vs JEPQ ($10,000, DRIP)

Year	CSBTF Portfolio	CSBTF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$11,418	$718.13	$11,930	$1,110.39	$512.00 → JEPQ
2	$12,984	$766.33	$14,133	$1,224.34	$1.1K → JEPQ
3	$14,707	$814.40	$16,632	$1,340.46	$1.9K → JEPQ
4	$16,599	$862.14	$19,454	$1,457.97	$2.9K → JEPQ
5	$18,670	$909.37	$22,626	$1,576.08	$4.0K → JEPQ
6	$20,933	$955.93	$26,175	$1,694.09	$5.2K → JEPQ
7	$23,400	$1,001.68	$30,133	$1,811.32	$6.7K → JEPQ
8	$26,084	$1,046.47	$34,531	$1,927.17	$8.4K → JEPQ
9	$29,000	$1,090.21	$39,403	$2,041.08	$10.4K → JEPQ
10	$32,163	$1,132.80	$44,787	$2,152.59	$12.6K → JEPQ

CSBTF vs JEPQ: Complete Analysis 2026

CSBTF — Stock

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products comprise KUR-111, which has completed Phase 2b clinical trial for the treatment of tibial plateau fractures; and KUR-113, which completed Phase 2b clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase II trial for the treatment of spinal interbody fusion. The company's sealants pipeline products include Neuroseal EU and US, synthetic tissue sealant for the prevention of cerebrospinal fluid leakage following cranial or spinal surgery. It has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. The company is headquartered in Schlieren, Switzerland.

Full CSBTF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this CSBTF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSBTF vs SCHD CSBTF vs JEPI CSBTF vs O CSBTF vs KO CSBTF vs MAIN CSBTF vs XYLD CSBTF vs QYLD CSBTF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.